APO Research
Talk to an analyst

APO RESEARCH · REPORT

Autoimmune Disease Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Autoimmune Disease Diagnostics Market Analysis and Forecast 2026-2032

20 December 2025215 pages

Choose your research edition.

Industry ResearchAutoimmune Disease Diagnostics Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Autoimmune Disease Diagnostics Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Autoimmune Disease Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Autoimmune Disease Diagnostics Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Autoimmune Disease Diagnostics Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Autoimmune Disease Diagnostics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Autoimmune Disease Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Autoimmune Disease Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Autoimmune Disease Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Autoimmune Disease Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Autoimmune Disease Diagnostics include Abbott Laboratories, Autoimmune Technologies, Avant Diagnostics, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, ERBA Diagnostics, Euro Diagnostica and EUROIMMUN, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Autoimmune Disease Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Autoimmune Disease Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Autoimmune Disease Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Autoimmune Disease Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Autoimmune Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Autoimmune Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Autoimmune Disease Diagnostics Segment by Company

Abbott Laboratories

Autoimmune Technologies

Avant Diagnostics

Beckman Coulter

Bio-Rad Laboratories

DiaSorin

ERBA Diagnostics

Euro Diagnostica

EUROIMMUN

Exagen Diagnostics

Gold Standard Diagnostics

HOB Diagnostics

HUMAN Diagnostics

Immco Diagnostics

ImmunArray

Inova Diagnostics

Myriad Genetics

Omega Diagnostics

ORGENTEC Diagnostika

Phadia

Protagen

Roche Diagnostics

Siemens Healthcare

Autoimmune Disease Diagnostics Segment by Type

Analyzers

Assay Kits

Autoimmune Disease Diagnostics Segment by Application

Hospitals

Research Laboratories

Autoimmune Disease Diagnostics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmune Disease Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Autoimmune Disease Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmune Disease Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Autoimmune Disease Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Autoimmune Disease Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autoimmune Disease Diagnostics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Analyzers Major Player Table 3. Assay Kits Major Player Table 4. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Research Laboratories Major Player Table 7. Autoimmune Disease Diagnostics Industry Trends Table 8. Autoimmune Disease Diagnostics Industry Drivers Table 9. Autoimmune Disease Diagnostics Industry Opportunities and Challenges Table 10. Autoimmune Disease Diagnostics Industry Restraints Table 11. Global Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Autoimmune Disease Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Autoimmune Disease Diagnostics Market Share by Region (2021-2026) Table 14. Global Autoimmune Disease Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Autoimmune Disease Diagnostics Market Share by Region (2027-2032) Table 16. Global Autoimmune Disease Diagnostics Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2021-2026) Table 18. Global Autoimmune Disease Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Autoimmune Disease Diagnostics Key Players Headquarters & Area Served Table 20. Global Autoimmune Disease Diagnostics Players, Product Type & Application Table 21. Global Autoimmune Disease Diagnostics Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Autoimmune Disease Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Autoimmune Disease Diagnostics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Autoimmune Disease Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2021-2026) Table 28. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2027-2032) Table 29. Global Autoimmune Disease Diagnostics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Autoimmune Disease Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2021-2026) Table 33. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2027-2032) Table 34. Abbott Laboratories Company Information Table 35. Abbott Laboratories Business Overview Table 36. Abbott Laboratories Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Abbott Laboratories Autoimmune Disease Diagnostics Product Portfolio Table 38. Abbott Laboratories Recent Development Table 39. Autoimmune Technologies Company Information Table 40. Autoimmune Technologies Business Overview Table 41. Autoimmune Technologies Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Autoimmune Technologies Autoimmune Disease Diagnostics Product Portfolio Table 43. Autoimmune Technologies Recent Development Table 44. Avant Diagnostics Company Information Table 45. Avant Diagnostics Business Overview Table 46. Avant Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Avant Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 48. Avant Diagnostics Recent Development Table 49. Beckman Coulter Company Information Table 50. Beckman Coulter Business Overview Table 51. Beckman Coulter Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Beckman Coulter Autoimmune Disease Diagnostics Product Portfolio Table 53. Beckman Coulter Recent Development Table 54. Bio-Rad Laboratories Company Information Table 55. Bio-Rad Laboratories Business Overview Table 56. Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Portfolio Table 58. Bio-Rad Laboratories Recent Development Table 59. DiaSorin Company Information Table 60. DiaSorin Business Overview Table 61. DiaSorin Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. DiaSorin Autoimmune Disease Diagnostics Product Portfolio Table 63. DiaSorin Recent Development Table 64. ERBA Diagnostics Company Information Table 65. ERBA Diagnostics Business Overview Table 66. ERBA Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. ERBA Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 68. ERBA Diagnostics Recent Development Table 69. Euro Diagnostica Company Information Table 70. Euro Diagnostica Business Overview Table 71. Euro Diagnostica Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Euro Diagnostica Autoimmune Disease Diagnostics Product Portfolio Table 73. Euro Diagnostica Recent Development Table 74. EUROIMMUN Company Information Table 75. EUROIMMUN Business Overview Table 76. EUROIMMUN Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. EUROIMMUN Autoimmune Disease Diagnostics Product Portfolio Table 78. EUROIMMUN Recent Development Table 79. Exagen Diagnostics Company Information Table 80. Exagen Diagnostics Business Overview Table 81. Exagen Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Exagen Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 83. Exagen Diagnostics Recent Development Table 84. Gold Standard Diagnostics Company Information Table 85. Gold Standard Diagnostics Business Overview Table 86. Gold Standard Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 88. Gold Standard Diagnostics Recent Development Table 89. HOB Diagnostics Company Information Table 90. HOB Diagnostics Business Overview Table 91. HOB Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. HOB Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 93. HOB Diagnostics Recent Development Table 94. HUMAN Diagnostics Company Information Table 95. HUMAN Diagnostics Business Overview Table 96. HUMAN Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. HUMAN Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 98. HUMAN Diagnostics Recent Development Table 99. Immco Diagnostics Company Information Table 100. Immco Diagnostics Business Overview Table 101. Immco Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Immco Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 103. Immco Diagnostics Recent Development Table 104. ImmunArray Company Information Table 105. ImmunArray Business Overview Table 106. ImmunArray Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. ImmunArray Autoimmune Disease Diagnostics Product Portfolio Table 108. ImmunArray Recent Development Table 109. Inova Diagnostics Company Information Table 110. Inova Diagnostics Business Overview Table 111. Inova Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Inova Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 113. Inova Diagnostics Recent Development Table 114. Myriad Genetics Company Information Table 115. Myriad Genetics Business Overview Table 116. Myriad Genetics Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Myriad Genetics Autoimmune Disease Diagnostics Product Portfolio Table 118. Myriad Genetics Recent Development Table 119. Omega Diagnostics Company Information Table 120. Omega Diagnostics Business Overview Table 121. Omega Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Omega Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 123. Omega Diagnostics Recent Development Table 124. ORGENTEC Diagnostika Company Information Table 125. ORGENTEC Diagnostika Business Overview Table 126. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Portfolio Table 128. ORGENTEC Diagnostika Recent Development Table 129. Phadia Company Information Table 130. Phadia Business Overview Table 131. Phadia Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Phadia Autoimmune Disease Diagnostics Product Portfolio Table 133. Phadia Recent Development Table 134. Protagen Company Information Table 135. Protagen Business Overview Table 136. Protagen Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Protagen Autoimmune Disease Diagnostics Product Portfolio Table 138. Protagen Recent Development Table 139. Roche Diagnostics Company Information Table 140. Roche Diagnostics Business Overview Table 141. Roche Diagnostics Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Roche Diagnostics Autoimmune Disease Diagnostics Product Portfolio Table 143. Roche Diagnostics Recent Development Table 144. Siemens Healthcare Company Information Table 145. Siemens Healthcare Business Overview Table 146. Siemens Healthcare Autoimmune Disease Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Siemens Healthcare Autoimmune Disease Diagnostics Product Portfolio Table 148. Siemens Healthcare Recent Development Table 149. North America Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 150. North America Autoimmune Disease Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 151. North America Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 152. North America Autoimmune Disease Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 153. North America Autoimmune Disease Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 155. North America Autoimmune Disease Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 156. Europe Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 157. Europe Autoimmune Disease Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 158. Europe Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 159. Europe Autoimmune Disease Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 160. Europe Autoimmune Disease Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. Europe Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 162. Europe Autoimmune Disease Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 163. China Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 164. China Autoimmune Disease Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 165. China Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 166. China Autoimmune Disease Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Autoimmune Disease Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Autoimmune Disease Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Autoimmune Disease Diagnostics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Autoimmune Disease Diagnostics Revenue by Region (US$ Million) & (2021-2026) Table 173. Asia Autoimmune Disease Diagnostics Revenue by Region (US$ Million) & (2027-2032) Table 174. SAMEA Autoimmune Disease Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 175. SAMEA Autoimmune Disease Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 176. SAMEA Autoimmune Disease Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 177. SAMEA Autoimmune Disease Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 178. SAMEA Autoimmune Disease Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. SAMEA Autoimmune Disease Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 180. SAMEA Autoimmune Disease Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Autoimmune Disease Diagnostics Image Figure 2. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Autoimmune Disease Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Analyzers Image Figure 5. Assay Kits Image Figure 6. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Autoimmune Disease Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Research Laboratories Image Figure 10. Global Autoimmune Disease Diagnostics Market Size (US$ Million) & (2021-2032) Figure 11. Global Autoimmune Disease Diagnostics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Autoimmune Disease Diagnostics Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Autoimmune Disease Diagnostics Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Autoimmune Disease Diagnostics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Autoimmune Disease Diagnostics Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2021-2032) Figure 18. Global Autoimmune Disease Diagnostics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2021-2032) Figure 21. North America Autoimmune Disease Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032) Figure 23. North America Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032) Figure 24. North America Autoimmune Disease Diagnostics Revenue Share by Country (2021-2032) Figure 25. United States Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Autoimmune Disease Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032) Figure 30. Europe Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032) Figure 31. Europe Autoimmune Disease Diagnostics Revenue Share by Country (2021-2032) Figure 32. Germany Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Autoimmune Disease Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032) Figure 42. China Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032) Figure 43. Asia Autoimmune Disease Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032) Figure 45. Asia Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032) Figure 46. Asia Autoimmune Disease Diagnostics Revenue Share by Region (2021-2032) Figure 47. Japan Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Autoimmune Disease Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032) Figure 55. SAMEA Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032) Figure 56. SAMEA Autoimmune Disease Diagnostics Revenue Share by Country (2021-2032) Figure 57. Brazil Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Autoimmune Disease Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Analyzers
  • Assay Kits
Applications
  • Hospitals
  • Research Laboratories
Companies covered
  • Abbott Laboratories
  • Autoimmune Technologies
  • Avant Diagnostics
  • Beckman Coulter
  • Bio-Rad Laboratories
  • DiaSorin
  • ERBA Diagnostics
  • Euro Diagnostica
  • EUROIMMUN
  • Exagen Diagnostics
  • Gold Standard Diagnostics
  • HOB Diagnostics
  • HUMAN Diagnostics
  • Immco Diagnostics
  • ImmunArray
  • Inova Diagnostics
  • Myriad Genetics
  • Omega Diagnostics
  • ORGENTEC Diagnostika
  • Phadia
  • Protagen
  • Roche Diagnostics
  • Siemens Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Autoimmune Disease Diagnostics Market by Type
  3. 1.2.1 Global Autoimmune Disease Diagnostics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Analyzers
  5. 1.2.3 Assay Kits
  6. 1.3 Autoimmune Disease Diagnostics Market by Application
  7. 1.3.1 Global Autoimmune Disease Diagnostics Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Research Laboratories
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Autoimmune Disease Diagnostics Market Dynamics
  1. 2.1 Autoimmune Disease Diagnostics Industry Trends
  2. 2.2 Autoimmune Disease Diagnostics Industry Drivers
  3. 2.3 Autoimmune Disease Diagnostics Industry Opportunities and Challenges
  4. 2.4 Autoimmune Disease Diagnostics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Autoimmune Disease Diagnostics Market Perspective (2021-2032)
  2. 3.2 Global Autoimmune Disease Diagnostics Growth Trends by Region
  3. 3.2.1 Global Autoimmune Disease Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Autoimmune Disease Diagnostics Market Size by Region (2021-2026)
  5. 3.2.3 Global Autoimmune Disease Diagnostics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Autoimmune Disease Diagnostics Revenue by Players
  2. 4.1.1 Global Autoimmune Disease Diagnostics Revenue by Players (2021-2026)
  3. 4.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Autoimmune Disease Diagnostics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Autoimmune Disease Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Autoimmune Disease Diagnostics Key Players Headquarters & Area Served
  7. 4.4 Global Autoimmune Disease Diagnostics Players, Product Type & Application
  8. 4.5 Global Autoimmune Disease Diagnostics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Autoimmune Disease Diagnostics Market CR5 and HHI
  11. 4.6.3 2025 Autoimmune Disease Diagnostics Tier 1, Tier 2, and Tier 3
5 Autoimmune Disease Diagnostics Market Size by Type
  1. 5.1 Global Autoimmune Disease Diagnostics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Autoimmune Disease Diagnostics Revenue by Type (2021-2032)
  3. 5.3 Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2021-2032)
6 Autoimmune Disease Diagnostics Market Size by Application
  1. 6.1 Global Autoimmune Disease Diagnostics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Autoimmune Disease Diagnostics Revenue by Application (2021-2032)
  3. 6.3 Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott Laboratories
  2. 7.1.1 Abbott Laboratories Company Information
  3. 7.1.2 Abbott Laboratories Business Overview
  4. 7.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Laboratories Autoimmune Disease Diagnostics Product Portfolio
  6. 7.1.5 Abbott Laboratories Recent Developments
  7. 7.2 Autoimmune Technologies
  8. 7.2.1 Autoimmune Technologies Company Information
  9. 7.2.2 Autoimmune Technologies Business Overview
  10. 7.2.3 Autoimmune Technologies Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Autoimmune Technologies Autoimmune Disease Diagnostics Product Portfolio
  12. 7.2.5 Autoimmune Technologies Recent Developments
  13. 7.3 Avant Diagnostics
  14. 7.3.1 Avant Diagnostics Company Information
  15. 7.3.2 Avant Diagnostics Business Overview
  16. 7.3.3 Avant Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Avant Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  18. 7.3.5 Avant Diagnostics Recent Developments
  19. 7.4 Beckman Coulter
  20. 7.4.1 Beckman Coulter Company Information
  21. 7.4.2 Beckman Coulter Business Overview
  22. 7.4.3 Beckman Coulter Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Beckman Coulter Autoimmune Disease Diagnostics Product Portfolio
  24. 7.4.5 Beckman Coulter Recent Developments
  25. 7.5 Bio-Rad Laboratories
  26. 7.5.1 Bio-Rad Laboratories Company Information
  27. 7.5.2 Bio-Rad Laboratories Business Overview
  28. 7.5.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Portfolio
  30. 7.5.5 Bio-Rad Laboratories Recent Developments
  31. 7.6 DiaSorin
  32. 7.6.1 DiaSorin Company Information
  33. 7.6.2 DiaSorin Business Overview
  34. 7.6.3 DiaSorin Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 DiaSorin Autoimmune Disease Diagnostics Product Portfolio
  36. 7.6.5 DiaSorin Recent Developments
  37. 7.7 ERBA Diagnostics
  38. 7.7.1 ERBA Diagnostics Company Information
  39. 7.7.2 ERBA Diagnostics Business Overview
  40. 7.7.3 ERBA Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ERBA Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  42. 7.7.5 ERBA Diagnostics Recent Developments
  43. 7.8 Euro Diagnostica
  44. 7.8.1 Euro Diagnostica Company Information
  45. 7.8.2 Euro Diagnostica Business Overview
  46. 7.8.3 Euro Diagnostica Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Euro Diagnostica Autoimmune Disease Diagnostics Product Portfolio
  48. 7.8.5 Euro Diagnostica Recent Developments
  49. 7.9 EUROIMMUN
  50. 7.9.1 EUROIMMUN Company Information
  51. 7.9.2 EUROIMMUN Business Overview
  52. 7.9.3 EUROIMMUN Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 EUROIMMUN Autoimmune Disease Diagnostics Product Portfolio
  54. 7.9.5 EUROIMMUN Recent Developments
  55. 7.10 Exagen Diagnostics
  56. 7.10.1 Exagen Diagnostics Company Information
  57. 7.10.2 Exagen Diagnostics Business Overview
  58. 7.10.3 Exagen Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Exagen Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  60. 7.10.5 Exagen Diagnostics Recent Developments
  61. 7.11 Gold Standard Diagnostics
  62. 7.11.1 Gold Standard Diagnostics Company Information
  63. 7.11.2 Gold Standard Diagnostics Business Overview
  64. 7.11.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  66. 7.11.5 Gold Standard Diagnostics Recent Developments
  67. 7.12 HOB Diagnostics
  68. 7.12.1 HOB Diagnostics Company Information
  69. 7.12.2 HOB Diagnostics Business Overview
  70. 7.12.3 HOB Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 HOB Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  72. 7.12.5 HOB Diagnostics Recent Developments
  73. 7.13 HUMAN Diagnostics
  74. 7.13.1 HUMAN Diagnostics Company Information
  75. 7.13.2 HUMAN Diagnostics Business Overview
  76. 7.13.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 HUMAN Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  78. 7.13.5 HUMAN Diagnostics Recent Developments
  79. 7.14 Immco Diagnostics
  80. 7.14.1 Immco Diagnostics Company Information
  81. 7.14.2 Immco Diagnostics Business Overview
  82. 7.14.3 Immco Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Immco Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  84. 7.14.5 Immco Diagnostics Recent Developments
  85. 7.15 ImmunArray
  86. 7.15.1 ImmunArray Company Information
  87. 7.15.2 ImmunArray Business Overview
  88. 7.15.3 ImmunArray Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  89. 7.15.4 ImmunArray Autoimmune Disease Diagnostics Product Portfolio
  90. 7.15.5 ImmunArray Recent Developments
  91. 7.16 Inova Diagnostics
  92. 7.16.1 Inova Diagnostics Company Information
  93. 7.16.2 Inova Diagnostics Business Overview
  94. 7.16.3 Inova Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Inova Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  96. 7.16.5 Inova Diagnostics Recent Developments
  97. 7.17 Myriad Genetics
  98. 7.17.1 Myriad Genetics Company Information
  99. 7.17.2 Myriad Genetics Business Overview
  100. 7.17.3 Myriad Genetics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Myriad Genetics Autoimmune Disease Diagnostics Product Portfolio
  102. 7.17.5 Myriad Genetics Recent Developments
  103. 7.18 Omega Diagnostics
  104. 7.18.1 Omega Diagnostics Company Information
  105. 7.18.2 Omega Diagnostics Business Overview
  106. 7.18.3 Omega Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Omega Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  108. 7.18.5 Omega Diagnostics Recent Developments
  109. 7.19 ORGENTEC Diagnostika
  110. 7.19.1 ORGENTEC Diagnostika Company Information
  111. 7.19.2 ORGENTEC Diagnostika Business Overview
  112. 7.19.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  113. 7.19.4 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Portfolio
  114. 7.19.5 ORGENTEC Diagnostika Recent Developments
  115. 7.20 Phadia
  116. 7.20.1 Phadia Company Information
  117. 7.20.2 Phadia Business Overview
  118. 7.20.3 Phadia Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Phadia Autoimmune Disease Diagnostics Product Portfolio
  120. 7.20.5 Phadia Recent Developments
  121. 7.21 Protagen
  122. 7.21.1 Protagen Company Information
  123. 7.21.2 Protagen Business Overview
  124. 7.21.3 Protagen Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Protagen Autoimmune Disease Diagnostics Product Portfolio
  126. 7.21.5 Protagen Recent Developments
  127. 7.22 Roche Diagnostics
  128. 7.22.1 Roche Diagnostics Company Information
  129. 7.22.2 Roche Diagnostics Business Overview
  130. 7.22.3 Roche Diagnostics Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Roche Diagnostics Autoimmune Disease Diagnostics Product Portfolio
  132. 7.22.5 Roche Diagnostics Recent Developments
  133. 7.23 Siemens Healthcare
  134. 7.23.1 Siemens Healthcare Company Information
  135. 7.23.2 Siemens Healthcare Business Overview
  136. 7.23.3 Siemens Healthcare Autoimmune Disease Diagnostics Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Siemens Healthcare Autoimmune Disease Diagnostics Product Portfolio
  138. 7.23.5 Siemens Healthcare Recent Developments
8 North America
  1. 8.1 North America Autoimmune Disease Diagnostics Revenue (2021-2032)
  2. 8.2 North America Autoimmune Disease Diagnostics Revenue by Type (2021-2032)
  3. 8.2.1 North America Autoimmune Disease Diagnostics Revenue by Type (2021-2026)
  4. 8.2.2 North America Autoimmune Disease Diagnostics Revenue by Type (2027-2032)
  5. 8.3 North America Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032)
  6. 8.4 North America Autoimmune Disease Diagnostics Revenue by Application (2021-2032)
  7. 8.4.1 North America Autoimmune Disease Diagnostics Revenue by Application (2021-2026)
  8. 8.4.2 North America Autoimmune Disease Diagnostics Revenue by Application (2027-2032)
  9. 8.5 North America Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032)
  10. 8.6 North America Autoimmune Disease Diagnostics Revenue by Country
  11. 8.6.1 North America Autoimmune Disease Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Autoimmune Disease Diagnostics Revenue by Country (2021-2026)
  13. 8.6.3 North America Autoimmune Disease Diagnostics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Autoimmune Disease Diagnostics Revenue (2021-2032)
  2. 9.2 Europe Autoimmune Disease Diagnostics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Autoimmune Disease Diagnostics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Autoimmune Disease Diagnostics Revenue by Type (2027-2032)
  5. 9.3 Europe Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Autoimmune Disease Diagnostics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Autoimmune Disease Diagnostics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Autoimmune Disease Diagnostics Revenue by Application (2027-2032)
  9. 9.5 Europe Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Autoimmune Disease Diagnostics Revenue by Country
  11. 9.6.1 Europe Autoimmune Disease Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Autoimmune Disease Diagnostics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Autoimmune Disease Diagnostics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Autoimmune Disease Diagnostics Revenue (2021-2032)
  2. 10.2 China Autoimmune Disease Diagnostics Revenue by Type (2021-2032)
  3. 10.2.1 China Autoimmune Disease Diagnostics Revenue by Type (2021-2026)
  4. 10.2.2 China Autoimmune Disease Diagnostics Revenue by Type (2027-2032)
  5. 10.3 China Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032)
  6. 10.4 China Autoimmune Disease Diagnostics Revenue by Application (2021-2032)
  7. 10.4.1 China Autoimmune Disease Diagnostics Revenue by Application (2021-2026)
  8. 10.4.2 China Autoimmune Disease Diagnostics Revenue by Application (2027-2032)
  9. 10.5 China Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Autoimmune Disease Diagnostics Revenue (2021-2032)
  2. 11.2 Asia Autoimmune Disease Diagnostics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Autoimmune Disease Diagnostics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Autoimmune Disease Diagnostics Revenue by Type (2027-2032)
  5. 11.3 Asia Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Autoimmune Disease Diagnostics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Autoimmune Disease Diagnostics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Autoimmune Disease Diagnostics Revenue by Application (2027-2032)
  9. 11.5 Asia Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Autoimmune Disease Diagnostics Revenue by Country
  11. 11.6.1 Asia Autoimmune Disease Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Autoimmune Disease Diagnostics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Autoimmune Disease Diagnostics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Autoimmune Disease Diagnostics Revenue (2021-2032)
  2. 12.2 SAMEA Autoimmune Disease Diagnostics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Autoimmune Disease Diagnostics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Autoimmune Disease Diagnostics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Autoimmune Disease Diagnostics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Autoimmune Disease Diagnostics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Autoimmune Disease Diagnostics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Autoimmune Disease Diagnostics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Autoimmune Disease Diagnostics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Autoimmune Disease Diagnostics Revenue by Country
  11. 12.6.1 SAMEA Autoimmune Disease Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Autoimmune Disease Diagnostics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Autoimmune Disease Diagnostics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst